TY  - JOUR
AU  - Wolffenbuttel, B. H. R.
AU  - Van Gaal, L.
AU  - Duran-Garcia, S.
AU  - Han, J.
PY  - 2016
DO  - 10.1111/dom.12669
SN  - 1462-8902
UR  - http://hdl.handle.net/10668/18985
T2  - Diabetes obesity & metabolism
AB  - This post hoc analysis assessed the evidence behind common reimbursement practices by evaluating the relationship of body mass index (BMI) ranges (35 kg/m(2)) with treatment effects of exenatide twice daily among patients with type 2 diabetes....
LA  - en
PB  - Wiley
KW  - body mass index
KW  - exenatide twice daily
KW  - type 2 diabetes
KW  - Peptide-1 receptor agonist
KW  - Basal insulin
KW  - Bolus insulin
KW  - Safety
KW  - Liraglutide
KW  - Management
KW  - Degludec
TI  - Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes
TY  - research article
VL  - 18
ER  -